Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision entry v3.4.2 was added, and notices about governmental funding and the previous revision v3.4.1 were removed. These changes are administrative in nature and do not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded UI elements Show glossary and a new label 'Last Update Submitted that Met QC Criteria'; updated footer items to display 'No FEAR Act Data' and 'Revision: v3.4.0'. Removed the older label 'Last Update that met QC Criteria', the older 'No FEAR Act data', and the prior 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4. No study details or user-facing functionality are affected.SummaryDifference0.1%

- Check63 days agoChange DetectedDifference0.6%

- Check92 days agoChange DetectedPublications section description updated to note items are automatically filled from PubMed and may not be about the study; the page revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.